Lymph node ratio versus TNM system as prognostic factor in colorectal cancer staging. A single Center experience
This study aims to establish the actual validity of the lymph node ratio (LNR) as a prognostic factor for colorectal cancer patients, and to verify differences of survival and disease-free interval.
Main Authors: | Moccia Francesco, Tolone Salvatore, Allaria Alfredo, Napolitano Vincenzo, Rosa D’Amico, Ilaria Ferrante, Ottavia Manto, Cesaro Edoardo, Docimo Ludovico, Fei Landino |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2019-07-01
|
Series: | Open Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1515/med-2019-0058 |
Similar Items
-
Rethinking the TNM Classification Regarding Direct Lymph Node Invasion in Pancreatic Ductal Adenocarcinoma
by: Fiona Speichinger, et al.
Published: (2021-12-01) -
A retrospective study analyzing if lymph node ratio carbon nanoparticles predict stage III rectal cancer recurrence
by: Feng Pi, et al.
Published: (2023-10-01) -
Tumor deposits in colorectal cancer: Refining their definition in the TNM system
by: Hideki Ueno, et al.
Published: (2023-03-01) -
The proposed modification of TNM staging and therapeutic strategy for skip metastasis in papillary thyroid carcinoma: A multicenter retrospective cohort study
by: Zheyu Yang, et al.
Published: (2023-06-01) -
Impact of prophylactic central lymph node dissection on the complications and recurrence rates in papillary thyroid carcinoma—An AFCE (French‐speaking Association of Endocrine Surgery) multicentre study based on the EUROCRINE® national data
by: Nathalie Chereau, et al.
Published: (2024-02-01)